Effects of metoprolol (M CR/Zok) on the physical endurance performance of patients with arterial hypertension

Clinical Drug Investigation

Volumn 17, Issue 4, 1999, Pages 255-263

  Wittke, R ^a,b   Kemmler, W ^a  

^a UNIVERSITY OF BAYREUTH   (Germany)

^b Sportmedizinisches Institut Bayreuth   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; GLUCOSE; HYDROCORTISONE; LACTIC ACID; METOPROLOL; OXYGEN;

ADULT; ANAEROBIC THRESHOLD; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ERGOMETRY; EXERCISE; GLUCOSE BLOOD LEVEL; GLYCOLYSIS; HEART RATE; HUMAN; HYPERTENSION; LACTATE BLOOD LEVEL; LUNG MINUTE VOLUME; ORAL DRUG ADMINISTRATION; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY QUOTIENT; SPORT; SYSTOLIC BLOOD PRESSURE;

EID: 0032954996     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199917040-00001     Document Type: Article

References (30)

1. 1. Epstein SE, Robinson BF. Effect of beta-adrenergic blockade on the cardial response to maximal and submaximal exercise in man. J Clin Invest 1965; 44: 1745-53
2. 2. Ekblom B, Goldberg AN. Effects of atropine and propranolol on the oxygen transport-system during exercise in man. Scand J Clin Lab Invest 1972; 30: 35-42
3. 3. Bruce RA, Hossack KF. Acute effects of oral propranolol on hemodynamic response to upright exercise. Am J Cardiol 1979; 44: 132-40
4. 4. Pearson SB, Banks CD. The effect of beta-adrenoceptor blockade on factors affecting exercise tolerance in normal man. Br J Clin Pharmacol 1979; 8: 143-8
5. 5. Folgering H, van Bursel M. Maximal exercise power after a single dose of metoprolol and of slow release metoprolol. Br J Clin Pharmacol 1980; 18: 225-9
6. 6. Wilmore JH, Bean J. Acute response to submaximal and maximal exercise consequent to beta-adrenergic blockade. Am J Cardiol 1985; 55: 135D-141D
7. 7. Schmidt WM, Schnabel A. Einfluß von Metoprolol auf die maximale und Ausdauerleistungsfähigkeit unter besonderer Berücksichtigung des Metabolismus. Sport- und Leistungsmedizin-Deutscher Sport-ärztekongreß 1980, Saarbrücken
8. 8. Vanhees L, Fagurd R. Effect of antihypertensive medication on endurance exercise capacity in hypertensive sportsmen. J Hypertens 1991; 1: 1063-8
9. 9. Anderson R, Wilmore J. Effects of cardioselective and nonselective beta-adrenergic blockade on the performance of highly trained runners. Am J Cardiol 1985; 55: 149D-154D
10. 10. Jackson G, Schwartz J. Atenolol, once-daily cardioselective beta blockade for angina pectoris. Circulation 1980; 61: 555-60
11. 11. Turner GG, Nelson RR. Comparative effect of nadolol and propranolol on exercise tolerance in patients with angina pectoris. Br Heart J 1978; 40: 1361-711
12. 12. Furberg C. Adrenergic beta blockade and physical working capacity. Acta Med Scand 1967; 182: 119-22
13. 13. Kaijser L, Kaiser P. Beta-blockers and running. Am Heart J 1980; 100: 943-4
14. 14. Kaiser P, Tesch P. Oxygen consumption and lactate metabolism during exercise following beta-adrenergic blockade. Drugs 1983; 25 Suppl. 2: 260-1
15. 15. Koebe P, Rost R. Der Einfluß unterschiedlicher Betarezeptorenblocker auf Stoffwechsel und Kreis-laufparameter während körperlicher Belastung. Drug Res 1985; 35 (1) 2: 522-9
16. 16. Gullestad L, Dolva L. Difference between beta-1-selective and nonselective beta blockade during continuous and intermittent exercise. Clin Physiol 1988; 8: 487-99
17. 17. Head A, Kendall MJ. Exercise metabolism during 1 hour of treadmill walking while taking high and low doses of proprnolol, metoprolol or placebo. Clin Cardiol 1995; 18: 335-40
18. 18. Koch G, Franz W, Lohmann F. Effects of short term and long term treatment with cardioselective and nonselective beta receptor blockade on carbohydrate and lipid metabolism and on catecholamines at rest and during exercise. Clin Sci 1981; 61 Suppl. 7: 432-5
19. 19. Akklaghi S, Maxwell RJ, Kendall MJ. A comparison of beta-1-selectivity of conventional metoprolol and metoprolol CR during exercise in healthy volunteers. J Clin Pharm Ther 1993; 18: 259-66
20. 20. Head A, Maxwell S, Kendall MJ. Exercise metabolism in healthy volunteers taking atenolol, high and low doses of metoprolol CR/Zok, and placebo. Br J Clin Pharmacol 1994; 38: 499-504
21. 21. Ronnevik PK, Nordrehang JE. Functional capacity in healthy volunteers before and following beta blockade with controlled release metoprolol. Eur J Clin Pharmacol 1995; 48: 127-31
22. 22. Hollmann W, Friedmann G. Übet das Verhalten der Herzgröße während dosierter Arbeit unter Betarezeptorenblockade. Med Welt 1972; 23: 1094-5
23. 23. Roskam H, Shinnes J. Die Kontraktilitätsreserve des gesunden linken Ventrikels bei körperlicher Belastung nach Betarezeptorenblockade. Z Kreislaufforschung 1972; 61: 802-11
24. 24. Liesen H, Hollmann W. Untersuchungen über den Einfluß von Propranolol auf die kardiopulmonalen und meta-bolischen Parameter bei dosierter Arbeit. Verb Dtsche Ges Kreislaufforsehung 1971; 37: 180-6
25. 25. Neumann G, Schüler KP. Sportmedizinische Funktionsdiagnostik. J Ambrosius-Barth-Verlag Leipzig-Berlin 1994; Seite 87-88
26. 26. Juklin-Dannfelt A. Beta-adrenoceptor-blockade and exercise: Effects of endurance and physical training. Acta Meal Scand 1983; Suppl. 672; 49-54
27. 27. Frish-Holmberg M, Jorfeldt L. Metabolic effects in muscle during antihypertensive therapy with beta-1- and beta-1/2-adrenoceptor blockers. Clin Pharmacol Ther 1981; 30: 611-8
28. 28. Cleroux J, Leenen FH. Effects of beta-blockade on muscle metabolism during prolonged exercise. Am J Hypertens 1988; 1: 2905-45
29. 29. van Baak MA, Mooij JM. Effect of increased plasma non esterified fatty acid concentration on endurance performance during beta-adrenoceptor blockade. Int J Sports Med 1993; 14: 2-8
30. 30. Gullestad L, Dolva OL. Effect of beta-adrenergic blockade on hormonal responses during continuous and intermittent exercise. Cardiovasc Drugs Ther 1989; 3: 63-71